AIDS Effort Suffers Big Blow as Merck Vaccine Fails.

The article reports on the failure of the experimental AIDS vaccine of Merck & Co. to prevent test subjects from becoming infected with HIV as well as offer indication that it might delay the onset of full-blown AIDS. Mark Feinberg of Merck has expressed disappointment over the failure of this trial which was considered the leading edge of research on T-cell based HIV vaccines.